Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Fiona Gaughran

Showing results (121-130 of 190) with videos related to

Pageof 19
Sort By:
World Psychiatry : Official Journal of the World Psychiatric Association (WPA)|June 7, 2016
Diabetes mellitus in people with schizophrenia, bipolar disorder and major depressive disorder: a systematic review and large scale meta-analysisDavy Vancampfort, Christoph U Correll, Britta Galling, et al.
The British Journal of Psychiatry : the Journal of Mental Science|October 2, 2024
Mortality associated with clozapine: what is the evidence?Emilio Fernandez-Egea, Robert J Flanagan, David Taylor, et al.
The Lancet. Psychiatry|June 30, 2022
Relaxation of the criteria for entry to the UK Clozapine Central Non-Rechallenge Database: a modelling studyEbenezer Oloyede, Eromona Whiskey, Cecilia Casetta, et al.
Schizophrenia Bulletin|February 5, 2021
There Is Life After the UK Clozapine Central Non-Rechallenge DatabaseEbenezer Oloyede, Cecilia Casetta, Olubanke Dzahini, et al.
Schizophrenia Research|September 14, 2021
Increased rates of respiratory disease in schizophrenia: A systematic review and meta-analysis including 619,214 individuals with schizophrenia and 52,159,551 controlsShuichi Suetani, Faraz Honarparvar, Dan Siskind, et al.
Schizophrenia Research|June 5, 2016
How much physical activity do people with schizophrenia engage in? A systematic review, comparative meta-analysis and meta-regressionBrendon Stubbs, Joseph Firth, Alexandra Berry, et al.
Pilot and Feasibility Studies|June 1, 2021
A feasibility hybrid II randomised controlled trial of volunteer 'Health Champions' supporting people with serious mental illness manage their physical health: study protocolJulie Williams, Elliann Fairbairn, Ray McGrath, et al.
World Psychiatry : Official Journal of the World Psychiatric Association (WPA)|January 3, 2019
The impact of pharmacological and non-pharmacological interventions to improve physical health outcomes in people with schizophrenia: a meta-review of meta-analyses of randomized controlled trialsDavy Vancampfort, Joseph Firth, Christoph U Correll, et al.
BMC Medicine|November 23, 2016
Physical multimorbidity and psychosis: comprehensive cross sectional analysis including 242,952 people across 48 low- and middle-income countriesBrendon Stubbs, Ai Koyanagi, Nicola Veronese, et al.
Focus (American Psychiatric Publishing)|September 6, 2021
The Impact of Pharmacological and Non-Pharmacological Interventions to Improve Physical Health Outcomes in People With Schizophrenia: A Meta-Review of Meta-Analyses of Randomized Controlled TrialsDavy Vancampfort, Joseph Firth, Christoph U Correll, et al.
Pageof 19

Showing results (121-130 of 190) with videos related to

Sort By:
Pageof 19
World Psychiatry : Official Journal of the World Psychiatric Association (WPA)|June 7, 2016
Diabetes mellitus in people with schizophrenia, bipolar disorder and major depressive disorder: a systematic review and large scale meta-analysisDavy Vancampfort, Christoph U Correll, Britta Galling, et al.
The British Journal of Psychiatry : the Journal of Mental Science|October 2, 2024
Mortality associated with clozapine: what is the evidence?Emilio Fernandez-Egea, Robert J Flanagan, David Taylor, et al.
The Lancet. Psychiatry|June 30, 2022
Relaxation of the criteria for entry to the UK Clozapine Central Non-Rechallenge Database: a modelling studyEbenezer Oloyede, Eromona Whiskey, Cecilia Casetta, et al.
Schizophrenia Bulletin|February 5, 2021
There Is Life After the UK Clozapine Central Non-Rechallenge DatabaseEbenezer Oloyede, Cecilia Casetta, Olubanke Dzahini, et al.
Schizophrenia Research|September 14, 2021
Increased rates of respiratory disease in schizophrenia: A systematic review and meta-analysis including 619,214 individuals with schizophrenia and 52,159,551 controlsShuichi Suetani, Faraz Honarparvar, Dan Siskind, et al.
Schizophrenia Research|June 5, 2016
How much physical activity do people with schizophrenia engage in? A systematic review, comparative meta-analysis and meta-regressionBrendon Stubbs, Joseph Firth, Alexandra Berry, et al.
Pilot and Feasibility Studies|June 1, 2021
A feasibility hybrid II randomised controlled trial of volunteer 'Health Champions' supporting people with serious mental illness manage their physical health: study protocolJulie Williams, Elliann Fairbairn, Ray McGrath, et al.
World Psychiatry : Official Journal of the World Psychiatric Association (WPA)|January 3, 2019
The impact of pharmacological and non-pharmacological interventions to improve physical health outcomes in people with schizophrenia: a meta-review of meta-analyses of randomized controlled trialsDavy Vancampfort, Joseph Firth, Christoph U Correll, et al.
BMC Medicine|November 23, 2016
Physical multimorbidity and psychosis: comprehensive cross sectional analysis including 242,952 people across 48 low- and middle-income countriesBrendon Stubbs, Ai Koyanagi, Nicola Veronese, et al.
Focus (American Psychiatric Publishing)|September 6, 2021
The Impact of Pharmacological and Non-Pharmacological Interventions to Improve Physical Health Outcomes in People With Schizophrenia: A Meta-Review of Meta-Analyses of Randomized Controlled TrialsDavy Vancampfort, Joseph Firth, Christoph U Correll, et al.
Pageof 19